ANIP · Ani Pharmaceuticals Inc · Documents
$72.61
-1.14 (-1.55%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.67B
Shares
22.97M
Volume · Oct 23
318.61K
Avg daily vol (3M)
382.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-03-06 | 2023-02-28 | |
| 8-K | — | 2022-11-09 | — | |
| 10-Q | — | 2022-11-09 | 2022-09-30 | |
| 8-K | — | 2022-11-09 | — | |
| 8-K/A | — | 2022-08-08 | 2022-06-02 | |
| 10-Q | — | 2022-08-08 | 2022-06-30 | |
| 8-K | — | 2022-08-08 | — | |
| 8-K | — | 2022-06-02 | — | |
| 8-K | — | 2022-05-10 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-04-29 | 2022-04-27 | |
| DEFA14A | — | 2022-04-14 | — | |
| DEF 14A | — | 2022-03-25 | 2022-04-27 | |
| 8-K | — | 2022-03-23 | 2022-03-19 | |
| 8-K | — | 2022-03-15 | — | |
| 10-K | — | 2022-03-15 | 2021-12-31 | |
| 8-K | — | 2022-02-28 | 2022-02-23 | |
| 8-K | — | 2022-02-15 | — | |
| 8-K | — | 2022-01-24 | — | |
| S-3 | — | 2021-12-17 | — | |
| 8-K | — | 2021-11-26 | 2021-11-19 | |
| 8-K | — | 2021-11-04 | 2021-11-03 | |
| 8-K | — | 2021-11-03 | — | |
| 8-K | — | 2021-11-01 | — | |
| 10-Q | — | 2021-11-01 | 2021-09-30 | |
| 8-K | — | 2021-08-06 | — | |
| 10-Q | — | 2021-08-06 | 2021-06-30 | |
| 8-K | — | 2021-06-04 | 2021-06-02 | |
| 10-Q | — | 2021-05-07 | 2021-03-31 | |
| 8-K | — | 2021-05-07 | — | |
| DEFA14A | — | 2021-05-07 | — | |
| DEF 14A | — | 2021-04-29 | 2021-06-02 | |
| PRE 14A | — | 2021-04-19 | — | |
| 8-K | — | 2021-04-06 | — | |
| 10-K | — | 2021-03-11 | 2020-12-31 | |
| 8-K | — | 2021-03-09 | — | |
| 8-K | — | 2021-03-09 | 2021-03-08 | |
| DEFA14A | — | 2021-03-09 | — | |
| DEFA14A | — | 2021-03-09 | — | |
| 8-K | — | 2021-02-17 | 2021-02-11 | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-08-06 | 2020-08-05 | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| 8-K | — | 2020-08-03 | — | |
| S-3 | — | 2020-07-09 | — | |
| 8-K | — | 2020-06-11 | 2020-06-05 | |
| 8-K | — | 2020-06-01 | — | |
| DEFA14A | — | 2020-05-21 | — |
Showing 101–150 of 164 filings
Key facts
CIK
1023024
CUSIP
00182C103
13F (30d)
39 filings
39 filers
Visit website
Investor relations